SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Maintain Significant Stake in ALLIENT INC, Disclosing 10.6% Beneficial Ownership
Beneficial Ownership Statement
FMR LLC and its affiliates, along with Abigail P. Johnson, have filed an amended Schedule 13G, confirming their continued beneficial ownership of 10.6% of ALLIENT INC's common stock as of January 31, 2025.
Summary
- FMR LLC and Abigail P. Johnson, as reporting persons, have filed an Amendment No. 2 to Schedule 13G regarding their beneficial ownership of ALLIENT INC's common stock.
- As of January 31, 2025, FMR LLC and Abigail P. Johnson collectively beneficially own 1,789,649.92 shares of ALLIENT INC common stock.
- This represents 10.6% of the total outstanding common stock of ALLIENT INC.
- FMR LLC holds sole voting power over 1,789,223.00 shares and sole dispositive power over 1,789,649.92 shares.
- Abigail P. Johnson holds sole dispositive power over 1,789,649.92 shares.
- The filing indicates that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of ALLIENT INC.
- Several FMR LLC subsidiaries, including FIAM LLC, Fidelity Management & Research Company LLC, Fidelity Management Trust Company, and Strategic Advisers LLC, are identified as entities that beneficially own shares, with Fidelity Management & Research Company LLC owning 5% or more.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing (Schedule 13G) disclosing beneficial ownership. It contains no positive or negative operational or financial news, thus maintaining a neutral sentiment.
Positives
- The disclosure of a significant 10.6% stake by a major institutional investor like FMR LLC can signal confidence in ALLIENT INC's long-term prospects.
- The filing explicitly states that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control, indicating a passive investment strategy.
Future Outlook
This Schedule 13G filing does not contain any forward-looking statements or guidance regarding ALLIENT INC's future performance or strategic outlook. It solely reports beneficial ownership.
Management Comments
- "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ยงยง 240.14a-11."
Industry Context
This filing is a routine disclosure of institutional ownership, common within the financial industry for large asset managers like FMR LLC. It reflects a passive investment in ALLIENT INC, consistent with the typical investment strategies of such firms.
Comparison to Industry Standards
- As a standard Schedule 13G filing, this document adheres to SEC reporting requirements for beneficial ownership.
- It does not provide financial or operational results for comparison to industry benchmarks or specific comparable companies/projects.
- The 10.6% stake held by FMR LLC is a significant institutional position, aligning with typical large-cap institutional holdings.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership, potentially signaling long-term investor confidence.
Next Steps
- The document does not outline any specific future actions or milestones for ALLIENT INC or the reporting persons beyond the ongoing beneficial ownership.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC. |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2025-01-31 | Date of event which requires filing of this statement (reporting date for beneficial ownership). |
| 2025-02-06 | Signature date of the Schedule 13G filing. |
Keywords
ALLIENT INC, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Investment Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.